Treatment results of Langerhans cell histiocytosis with LSH II protocol;Výsledky léčby histiocytózy z Langerhansových buněk protokolem LCH II

Casopis Lekaru Ceskych

Volumn 144, Issue 11, 2005, Pages 753-755

  Mottl, Hubert ^a,b   Ganevova M ^a   Radvanska J ^a   Chanova M ^a   Smelhaus V ^a   Kodet, R ^a   Mrhalova M ^a   Tichy M ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b NONE   (Czech Republic)

Author keywords

Children; Langerhans cell histiocytosis; LCH II protocol; Outcome

Indexed keywords

CHLORODEOXYADENOSINE; DEOXYADENOSINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CANCER RADIOTHERAPY; CANCER REGRESSION; CHILD; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HISTIOCYTOSIS X; HUMAN; LANGERHANS CELL; MALE; MONOTHERAPY; RANDOMIZATION; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 28344448763     PISSN: 00087335     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Ladish, S., Jaffe, E. S.: The histiocytoses. In, Pizzo, P. A., Poplack, D. G., editors. Principles and practice of pediatric oncology. 4th edition. Philadelphia, Lippincott, 2002, s. 733-750.
2. Arico, M., Egeler, M.: Clinical aspects of Langerhans cell histiocytosis. Hematol. Oncol. Clin. North. Am., 1998, 12, s. 247-258.
3. Mottl, H., Mráček, J., Kabelka, Z. et al.: Histiocytóza z Langerhansových buněk u dětí. Čs. Pediatr., 1992, 47, s. 530-533.
4. Nezelof, C., Basset, F., Roussea, M. F., Histiocytosis, X.: Histogenic arguments for a Langerhans' cell origin. Biomedicine, 1973, 18, s. 365-371.
5. Komp, D. M.: Langerhans cell histiocytosis. N. Engl. J. Med., 1987, 316, s. 747-748.
6. Lahey, M. E.: Prognostic factors in histiocytosis X. Am. J. Pediatr. Hematol. Oncol., 1981, 3, s. 57-60.
7. Egeler, R. M., d'Angio, G. J.: Langerhans cell histiocytosis. J. Pediatrics., 1995, 127, s. 1-11.
8. Chu, T., d'Angio, G. J., Favara, B. et al.: Histiocytosis syndromes in children. Lancet, 1987, 306, s. 208-209.
9. Histiocyte Society. LCH II Treatment Protocol. May 1996.
10. Azouz, E. M., Saigal, G., Rodriguez, M. M., Podda, A.: Langerhans' cell histiocytosis, pathology, imaging and treatment of skeletal involvement. Pediatr. Radiol., 2005, 35, s. 103-115.
11. McCullough, C. J.: Eosinophilic granuloma of bone. Acta Orthop. Scand., 1980, 51, s. 389-398.
12. Histiocyte Society. LCH III Treatment Protocol. Apríl 2001.
13. Gadner, H., Grois, N., Arico, M. et al. Histiocyte Society. A randomized trial of treatment for multisystem Langerhans' cell histiocytosis. J. Pediatr., 2001, 138, s. 728-734.
14. Gadner, H., Heitger, A., Ritter, J. et al.: Langerhans cell histiocytosis in childhood- results of the DAL-HX 83 study. Klin. Pediatr., 1987, 199, s. 173-182.
15. Viana, M. B., Oliveira, B. M., Suva, C. M., Rios Leite, V. H.: Etoposide in the treatment of six children with Langerhans cell histiocytosis (histiocytosis X). Med. Pediatr. Oncol., 1991, 19, s. 289-294.
16. Ladisch, S., Gadner, H., Arico, M. et al.: LCH-I, a randomized trial of etoposide vs. vinblastine in disseminated Langerhans cell histiocytosis. The Histiocyte Society. Med. Pediatr. Oncol., 1994, 23, s. 107-110.
17. Yu, L. C., Shenoy, S., Ward, K., Warrier, R. P.: Successful treatment of multisystem Langerhans cell histiocytosis (histiocytosis X) with etoposide. Am. J. Pediatr. Hematol. Oncol., 1994, 16, s. 275-277.
18. Lopes, L. F., de Camargo, B.: Secondary acute promyelocytic leukemia after treatment with etoposide for Langerhans cell histiocytosis (LCH). Med. Pediatr. Oncol., 1999, 32, s. 315.
19. Le Deley, M. C., Vassal, G., Taibi, A. et al.: High cumulative rate of secondary leukemia after continuous etoposide treatment for solid tumors in children and young adults. Pediatr. Blood Cancer, 2005, 45, s. 25-31.
20. Minkov, M., Grois, N., Heitger, A. et al.: DAL- HX Study Group. Response to initial treatment of multisystem Langerhans cell histiocytosis, an important prognostic indicator. Med. Pediatr. Oncol., 2002, 39, s. 581-585.
21. Jubran, R. F., Marachelian, A., Dorey, F., Malogolowkin, M.: Predictors of outcome in children with Langerhans cell histiocytosis. Pediatr. Blood Cancer, 2005, 45, s. 37-42.
22. Minkov, M., Grois, N., Heitger, A. et al.: Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. DAL-HX Study Group. Klin Pediatr., 2000, 212, s. 139-144.
23. Goh, N. S., McDonald, C. E., MacGregor, D P. et al.: Successful treatment of Langerhans cell histiocytosis with 2-chlorodeoxyadenosine. Respirology, 2003, 8, s. 91-94.
24. Grau, J., Ribera, J. M., Tormo, M. et al.: Results of treatment with 2-chlorodeoxyadenosine in refractory or relapsed Langerhans cell histiocytosis. Study of 9 patients. Med. Clin. (Barc)., 2001, 116, s. 339-342.
25. Rodriguez-Galindo, C., Kelly, P., Jeng, M. et al.: Treatment of children with Langerhans cell histiocytosis with 2-chlorodeoxyadenosine. Am. J. Hematol., 2002, 69, s. 179-184.